UCB
The Principal Scientist leads translational biomarker projects that connect drug discovery programs with clinical development, evaluating mechanisms of action and pharmacokinetic and pharmacodynamic relationships. This role involves shaping biomarker strategy in autoimmune disease and translating complex data into clear program decisions. The position reports to the Executive Director, Translational Medicine and requires collaboration with multidisciplinary teams and external partners.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
Discovery Immunology Principal Research Scientist
Vertex
Principal Scientist - Cell Therapy Translational Research
Bristol Myers Squibb
Principal Scientist, Translational Immunology & High-Throughput Precision Biomarkers
MSD
Senior Director, Translational Medicine Lead – Autoimmune
Moderna
Scientist/Senior Scientist
Flagship Pioneering, Inc.
Senior Scientist, Translational Research (Oncology TRC)
Bristol Myers Squibb